Recent Advances in Epigenetics of Age-Related Kidney Diseases
- PMID: 35627181
- PMCID: PMC9142069
- DOI: 10.3390/genes13050796
Recent Advances in Epigenetics of Age-Related Kidney Diseases
Abstract
Renal aging has attracted increasing attention in today's aging society, as elderly people with advanced age are more susceptible to various kidney disorders such as acute kidney injury (AKI) and chronic kidney disease (CKD). There is no clear-cut universal mechanism for identifying age-related kidney diseases, and therefore, they pose a considerable medical and public health challenge. Epigenetics refers to the study of heritable modifications in the regulation of gene expression that do not require changes in the underlying genomic DNA sequence. A variety of epigenetic modifiers such as histone deacetylases (HDAC) inhibitors and DNA methyltransferase (DNMT) inhibitors have been proposed as potential biomarkers and therapeutic targets in numerous fields including cardiovascular diseases, immune system disease, nervous system diseases, and neoplasms. Accumulating evidence in recent years indicates that epigenetic modifications have been implicated in renal aging. However, no previous systematic review has been performed to systematically generalize the relationship between epigenetics and age-related kidney diseases. In this review, we aim to summarize the recent advances in epigenetic mechanisms of age-related kidney diseases as well as discuss the application of epigenetic modifiers as potential biomarkers and therapeutic targets in the field of age-related kidney diseases. In summary, the main types of epigenetic processes including DNA methylation, histone modifications, non-coding RNA (ncRNA) modulation have all been implicated in the progression of age-related kidney diseases, and therapeutic targeting of these processes will yield novel therapeutic strategies for the prevention and/or treatment of age-related kidney diseases.
Keywords: DNA methylation; age-related kidney diseases; epigenetics; histone modification; non-coding RNA regulation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Targeting epigenetic DNA and histone modifications to treat kidney disease.Nephrol Dial Transplant. 2018 Nov 1;33(11):1875-1886. doi: 10.1093/ndt/gfy009. Nephrol Dial Transplant. 2018. PMID: 29534238 Review.
-
Epigenetic targeting for acute kidney injury.Nephrology (Carlton). 2018 Oct;23 Suppl 4:21-25. doi: 10.1111/nep.13466. Nephrology (Carlton). 2018. PMID: 30298650 Review.
-
Recent developments in epigenetics of acute and chronic kidney diseases.Kidney Int. 2015 Aug;88(2):250-61. doi: 10.1038/ki.2015.148. Epub 2015 May 20. Kidney Int. 2015. PMID: 25993323 Free PMC article. Review.
-
Investigation of epigenetics in kidney cell biology.Methods Cell Biol. 2019;153:255-278. doi: 10.1016/bs.mcb.2019.04.015. Epub 2019 Jun 13. Methods Cell Biol. 2019. PMID: 31395383 Free PMC article. Review.
-
Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.Int J Cardiol. 2017 Jan 15;227:66-82. doi: 10.1016/j.ijcard.2016.11.204. Epub 2016 Nov 9. Int J Cardiol. 2017. PMID: 27852009 Review.
Cited by
-
Association between trough serum vancomycin concentration and vancomycin-associated acute kidney injury and 30-day mortality in critically ill elderly adults.BMC Infect Dis. 2024 Mar 20;24(1):330. doi: 10.1186/s12879-024-09227-x. BMC Infect Dis. 2024. PMID: 38509460 Free PMC article.
-
Pathogenic Role of MicroRNA Dysregulation in Podocytopathies.Front Physiol. 2022 Jun 29;13:948094. doi: 10.3389/fphys.2022.948094. eCollection 2022. Front Physiol. 2022. PMID: 35845986 Free PMC article. Review.
References
-
- Ye P., Er Y., Wang H., Fang L., Li B., Ivers R., Keay L., Duan L., Tian M. Burden of falls among people aged 60 years and older in mainland China, 1990–2019: Findings from the Global Burden of Disease Study 2019. Lancet Public Health. 2021;6:e907–e918. doi: 10.1016/S2468-2667(21)00231-0. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
